Video
2 Sep 2020
Pharmaceutical Industry in Korea 2020
Korean pharmaceutical and biopharmaceutical industry is expected to lead the global market, as globally competitive products and innovative technologies are being developed every day. Drug development capabilities and rapid globalization of K-Pharma make the industry very promising for the future.
Content provided by our supplier
Korea Health Industry Development Institute

-
KR
-
2020On CPHI since
Other Content from Korea Health Industry Development Institute (3)
-
Brochure Pharmaceutical Industry in Korea 2020
Korean pharmaceutical and biopharmaceutical industry is expected to lead the global market, as globally competitive products and innovative technologies are being developed every day. Drug development capabilities and rapid globalization of K-Pharma make the industry very promising for the future. -
Video Korea: Innovation & R&D Trends
This session will focus on the latest developments in the Korean biopharmaceutical market and look in-depth at R&D trends. Korea has emerged as a leading biopharmaceutical market, valued at around $18.6 billion with a annual growth rate of 7% from 2012 to 2018. Furthermore, the domestic biopharmaceutical industry is expanding internationally with the advancement of innovative technologies and has become a key growth engine for the Pharma industry in Korea. hear from global consultants on the strengths of Korea's Biopharma industry, who will share practical information and data on R&D, RA, Business Development and Marketing strategies. This is a great opportunity to gain cutting-edge insight from businesses who are scaling up for the future and building partnerships with domestic pharmaceutical companies. - Peptron : Smart Depot Platform and its applications - Olix Pharmaceuticals : OliX Pharmaceuticals: RNAi Therapeutics Company - HK inno.N : World P-CAB Leader, HK inno.N - Daewoong Pharmaceutical : Research & Development innovation with Daewoong's Platform Technology - Huons : Huons Corporate Presentation: Hu007 and Hutox - Ceres F&D : Introduction of Hyaluronidase and Tacrolimus Aired as part of the CPHI Festival of pharma -
Video Korean pharmaceutical companies' IR Session
Korea Health Industry Development Insititute(KHIDI) has prepared Korean IR session in order to enable Korean pharmaceutical companies to expand opportunity to enter into global market and have business meeting with other countries.2 foreign principal consultants in KHIDI provide brief explanation of Korean pharmaceutical industry and 6 companies introduce their company and their innovative technology and project.
You can meet their distinctive presentation below the google link.
Recently Visited
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance